Isorhamnetin Reverses Doxorubicin Resistance in MCF-7/Doxo Cells by Suppressing P-glycoprotein-mediated Drug Efflux and Reactivating Apoptosis
Doxorubicin resistance is a major challenge in breast cancer treatment, leading to cancer recurrence and poor therapeutic outcomes. Therefore, new agents that can overcome chemoresistance are urgently needed. Chemotherapy is widely used as a frontline treatment for breast cancer (BC), but chemoresistance to...